Join the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More information25th January 2022
To ensure effective and efficient safety assessment of clinical trials, the EU Commission published rules and procedures for the cooperation of the Member States. A risk-based approach should define the frequency of screening of safety information, the extent of its assessment and the timelines of assessment and reporting.